Lead sponsor
Shanghai Greenvalley Pharmaceutical Co., Ltd.
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
0
Ongoing
1,073
Total enrollment
39
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Phase 3
1
Trials by status
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's DiseaseAlzheimer's diseasePh 3Completed818
Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's DiseaseAlzheimer's diseasePh 2Completed255